Your Evolution Has Begun
WHERE SCIENCE
MEETS LONGEVITY
Anera is a clinically driven longevity company built at the intersection of
regenerative medicine, nanotechnology, and biologically intelligent health systems —
designed to extend both the quality and duration of human life.
WHY ANERA EXISTS
Truc Tran
Founder/Ceo
For decades, the healthcare industry has operated on a model built around disease
management rather than genuine restoration. Patients were handed prescriptions
designed to suppress symptoms, while the underlying biological dysfunction — the
root cause of accelerated aging and chronic illness — was left entirely unaddressed.
The founder of Anera witnessed this gap firsthand: brilliant clinicians constrained
by systems that rewarded treatment over transformation.
The Journey
The path to founding Anera was not a straight line. It began in clinical practice,
moved through years of independent research in regenerative science, and eventually
converged with a team of pioneering scientists whose work in nanometallic
therapeutics, epigenetics, and mitochondrial health pointed toward something
genuinely new. The question was no longer “how do we treat disease?” — it became
“how do we build a body that resists it?”
The Mission Behind Anera
Anera was founded on a singular conviction: that human beings deserve a healthcare
system as sophisticated as the biology it serves. By uniting clinical expertise
with cutting-edge longevity science, Anera is building protocols, products, and
platforms that don’t just extend lifespan — they elevate healthspan. Every
decision the company makes is anchored in peer-reviewed science, clinical
validation, and a deep respect for the complexity of human biology.
What Makes It Different
Unlike wellness brands that borrow the language of science without its rigor,
Anera operates at the frontier. With 90+ patents in nanometallic silver oxide
technology, a Scientific Advisory Board spanning integrative medicine, biological
dentistry, and AI-driven analytics, and a clinical framework rooted in regenerative
therapeutics, Anera represents a fundamentally different category — one where
innovation is not a marketing claim, but a measurable outcome.
MISSION, VISION & SCIENTIFIC APPROACH
01
Our Mission
To advance human health by delivering clinically validated, biologically intelligent
solutions that address the root causes of aging and disease — empowering individuals
to live longer, healthier, and more vibrant lives through the convergence of
regenerative medicine and precision science.
- Longevity science
- Regenerative medicine
- Biologically intelligent health systems
- Clinical innovation
02
Our Vision
A world in which biological aging is no longer an inevitable decline, but a
manageable, measurable process — one that every person has the tools to influence.
Anera envisions a global standard of care where regenerative science is accessible,
evidence-based, and integrated into every stage of life.
03
Our Scientific Approach
Every Anera protocol is grounded in peer-reviewed research and guided by a
multidisciplinary Scientific Advisory Board. Our approach integrates epigenetics,
mitochondrial optimization, microbiome science, nanometallic therapeutics, and
AI-driven longevity analytics into a unified clinical framework — built to deliver
measurable biological outcomes.
GUIDED BY PIONEERING SCIENCE
Dr. Andrew Willoughby
President & Chief Science Officer
90+ Patents
PBS Medical Innovations
Nanometallic Research
Regenerative Therapeutics
Dr. Andrew Willoughby is one of the most decorated scientists working at the
intersection of nanotechnology and regenerative medicine today. As President and
Chief Science Officer of Anera, he brings over three decades of research experience
and a portfolio of more than 90 patents that have reshaped how clinicians and
researchers think about nanometallic silver oxide technology and its therapeutic
applications.
His pioneering work in nanometallic silver oxide research has established entirely
new paradigms for antimicrobial and regenerative therapeutics — work that has been
validated in clinical settings and recognized by leading scientific institutions
worldwide. Dr. Willoughby’s research has demonstrated that nanometallic compounds,
when properly formulated and delivered, can interact with biological systems at the
cellular level to promote healing, reduce inflammation, and support tissue
regeneration.
Beyond the laboratory, Dr. Willoughby has been featured in PBS Medical Innovations,
bringing his research to broader audiences and advocating for the integration of
advanced nanotechnology into mainstream clinical practice. His ability to translate
complex science into accessible, actionable protocols has made him a trusted voice
in both the scientific community and the public health space.
At Anera, Dr. Willoughby leads the company’s scientific strategy, overseeing all
research and development initiatives, clinical trial design, and the ongoing
expansion of Anera’s proprietary technology platform. His vision is to build a
science infrastructure that is not only innovative, but reproducible, transparent,
and clinically meaningful.
THE MINDS BEHIND THE SCIENCE
Anera’s Scientific Advisory Board brings together world-class clinicians, researchers,
and innovators whose collective expertise guides the company’s research direction,
clinical strategy, and product development.
Manuel Riegner
Integrative & Longevity Medicine
A leading practitioner in integrative and longevity medicine, Manuel Riegner
brings a systems-based approach to patient care that bridges conventional
diagnostics with advanced regenerative protocols focused on optimizing biological
age and extending healthspan.
Dr. Dean Raffelock
Clinical Nutrition & Formulation
A recognized authority in clinical nutrition and nutraceutical formulation, with
decades of experience developing evidence-based supplementation protocols. His
expertise in micronutrient science and metabolic optimization directly informs
Anera’s product formulation strategy.
Dr. Keith Moeller
Nano-Metallic Silver Technology
A globally recognized pioneer in nano-metallic silver technology, with an
extensive publication and patent record in the field. His foundational research
into the antimicrobial and regenerative properties of silver nanoparticles forms
a cornerstone of Anera’s proprietary therapeutic platform.
Dr. Scott Chandler
Biological Dentistry
A leading voice in biological dentistry, championing the critical connection
between oral health and systemic wellness. His clinical practice and research
focus on biocompatible dental materials, detoxification protocols, and the role
of oral microbiome health in overall longevity.
Dr. Brad Labrecque
Nanotechnology Innovation
An innovator in applied nanotechnology with a focus on translating laboratory
breakthroughs into clinically viable therapeutics. His work in nanoparticle
delivery systems and bioavailability enhancement plays a key role in advancing
Anera’s next-generation product pipeline.
Dr. Craig Young
Oral-Systemic Health
A specialist in the emerging field of oral-systemic health, exploring the
bidirectional relationship between the oral cavity and the body’s broader
physiological systems. His research highlights how oral inflammation and
microbial imbalance can drive systemic disease.
Dr. Paul Sidhu
Longevity Medicine
A clinician and researcher dedicated to the science of longevity medicine, with
a particular focus on hormonal optimization, cellular senescence, and the
integration of wearable health data into personalized longevity protocols.
Dr. Kevin Mudrow
Biomimetic Dentistry
A specialist in biomimetic dentistry — a discipline focused on restoring teeth
to their natural form, function, and aesthetics using materials and techniques
that mimic natural tooth structure. His work informs Anera’s oral health
innovation strategy.
Dr. Gregory Eckel
Integrative Medicine
A practitioner and thought leader in integrative medicine, combining the best
of conventional and complementary approaches to support whole-person health.
His clinical philosophy — that the body has an innate capacity for healing when
given the right conditions — aligns closely with Anera’s core mission.
Advisor — Dr. Gabriel Alizaidy
Scientific Advisory Board
Anera continues to expand its Scientific Advisory Board with world-class experts
advancing the frontiers of longevity science, regenerative medicine, and clinical
innovation. An announcement is forthcoming.
THE PILLARS OF OUR RESEARCH
Anera’s research and clinical strategy is organized around five core scientific pillars,
each representing a frontier where the science of aging intersects with the possibility
of meaningful biological intervention.
01
Epigenetics
Understanding how environmental signals, lifestyle factors, and targeted
interventions can modify gene expression — without altering the underlying DNA
sequence — to slow biological aging and promote cellular resilience.
02
Mitochondrial Health
Optimizing the function of the cell’s energy-producing organelles to combat the
mitochondrial dysfunction that underlies many age-related diseases, cognitive
decline, and metabolic disorders — restoring cellular vitality at its source.
03
Microbiome Science
Mapping and modulating the complex ecosystem of microorganisms that inhabit the
human body — particularly the gut-brain axis — to reduce systemic inflammation,
improve immune function, and support the biological conditions for longevity.
04
Nanometallic Therapies
Leveraging the unique biological properties of nanometallic silver oxide compounds
— backed by 90+ patents — to develop next-generation antimicrobial,
anti-inflammatory, and regenerative therapeutics that operate at the cellular
and subcellular level.
05
AI-Driven Longevity Analytics
Deploying artificial intelligence and machine learning to analyze complex
biological datasets — from genomics and proteomics to wearable sensor data —
enabling personalized longevity protocols that adapt in real time to each
individual’s unique biological profile.